Treatment of pityriasis versicolor with bifonazole shampoo: a randomized double-blind study

被引:4
|
作者
Segal, R [1 ]
Kricheli, D [1 ]
Zukrov, B [1 ]
David, M [1 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Dept Dermatol, IL-49100 Petah Tiqwa, Israel
关键词
pityriasis versicolor; bifonazole shampoo;
D O I
10.3109/09546639909056026
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The application of a shampoo containing an antifungal agent is a convenient and useful means of treating pityriasis versicolor. The effect of bifonazole 1% shampoo on extensive pityriasis versicolor was assessed, and the optimal duration of treatment determined. A total of 30 patients with a diagnosis of pityriasis versicolor were allocated to one of three treatment groups (n = 10 each): (A) 2 days of bifonazole shampoo followed by 5 days of the vehicle only; (B) 7 days of bifonazole shampoo only; (C) 7 days of the vehicle only. Patients were seen after 1 and 6 weeks. Some of those showing no response after 1 week were treated 'openly' for 1 week with bifonazole shampoo. Four patients were lost to follow-up. After the first week, clinical and mycological cure was observed in ten patients, four (44%) in group A and six (75%) in group B, and an improvement in four patients, two in both group A and group B. Failure was seen in three group A patients and in all group C patients. Seven failed patients underwent 'open' treatment with bifonazole shampoo; after 1 week, six were cured and one showed no improvement. Two patients (one each from group A and group C) complained of a mild reversible pruritus. These findings indicate that bifonazole shampoo is significantly more effective than placebo in treating pityriasis versicolor; 7 days of treatment are preferable to 2 days.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 50 条
  • [1] Treatment of pityriasis versicolor with a shampoo containing 1% bifonazole (Agispor® shampoo) in children
    Amichai, B
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (08) : 660 - 660
  • [2] DOUBLE-BLIND-STUDY WITH FENTICONAZOLE OR BIFONAZOLE LOTIONS IN PITYRIASIS VERSICOLOR
    ASTE, N
    PAU, M
    CORDARO, CI
    BIGGIO, P
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1988, 8 (04) : 271 - 273
  • [3] Flutrimazole shampoo 1% ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial
    Rigopoulos, D.
    Gregoriou, S.
    Kontochristopoulos, G.
    Ifantides, A.
    Katsambas, A.
    MYCOSES, 2007, 50 (03) : 193 - 195
  • [4] TREATMENT WITH BIFONAZOLE SHAMPOO FOR SEBORRHEA AND SEBORRHEIC DERMATITIS - A RANDOMIZED, DOUBLE-BLIND-STUDY
    SEGAL, R
    DAVID, M
    INGBER, A
    LURIE, R
    SANDBANK, M
    ACTA DERMATO-VENEREOLOGICA, 1992, 72 (06) : 454 - 455
  • [5] TREATMENT OF PITYRIASIS VERSICOLOR WITH ITRACONAZOLE - A DOUBLE-BLIND PLACEBO CONTROLLED-STUDY
    FAERGEMANN, J
    MYCOSES, 1988, 31 (07) : 377 - 379
  • [6] DOUBLE-BLIND COMPARISON OF A ZINC PYRITHIONE SHAMPOO AND ITS SHAMPOO BASE IN THE TREATMENT OF TINEA VERSICOLOR
    FREDRIKSSON, T
    FAERGEMANN, J
    CUTIS, 1983, 31 (04): : 436 - 437
  • [7] The mycological efficacy and safety of selenium sulfide 1.8% versus ketoconazole 2% shampoo in pityriasis versicolor: A double-blind randomized controlled trial
    Lusiana
    Surachmiati, Lis
    Saldi, Siti Rizny Fitriana
    Lusianingtyas, Trah
    Bramono, Kusmarinah
    GERMS, 2022, 12 (04): : 452 - 460
  • [8] COMPARATIVE CLINICAL-TRIAL OF BIFONAZOLE SOLUTION VERSUS SELENIUM SULFIDE SHAMPOO IN THE TREATMENT OF PITYRIASIS VERSICOLOR
    CHU, AC
    DERMATOLOGICA, 1984, 169 : 81 - 86
  • [9] A double-blind, randomized, placebo-controlled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor
    Faergemann, Jan
    Todd, Gail
    Pather, Sandrakantha
    Vawda, Zubar F. A.
    Gillies, John D.
    Walford, Ted
    Barranco, Charles
    Quiring, John N.
    Briones, Manuel
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (06) : 971 - 976
  • [10] Ketoconazole 2% shampoo in the treatment of tinea versicolor: A multicenter, randomized, double-blind, placebo-controlled trial
    Lange, DS
    Richards, HM
    Guarnieri, J
    Humeniuk, JM
    Savin, RC
    Reyes, BA
    Hickman, J
    Pariser, DM
    Pariser, RJ
    Sherertz, EF
    Grossman, RM
    Gisoldi, EM
    Klausner, MA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (06) : 944 - 950